News
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Annual General Meeting of STS Group AG approves all proposed resolutions by a large majority
STS Group AG's Annual General Meeting approves all proposed resolutions by a large majority, including a dividend of EUR 0.041 per share and re-election of Supervisory Board members. Growth prospects confirmed for 2024 -
-
COMMUNIQUÉ DE PRESSE
Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
Seraxis, Inc. awarded $400,000 MSCRF grant to advance SR-03 cell line for diabetes treatment. Meeting at ADA Annual Meeting in Orlando